Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (2,520,475)	$ (2,099,895)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,204,609	1,168,773
Loss on inventory write - downs	42,826	0
Share-based compensation expense	220,832	43,443
Changes in operating assets and liabilities:
Accounts receivable	90,263	0
Inventory	19,948	337,805
Other current assets	107,531	297,707
Accrued expenses and others current liabilities	(338,003)	133,302
Net cash used in operating activities	(1,427,427)	(1,389,889)
Cash flows from investing activities:
Payment to acquisition of property and equipment	(72,184)	(135,899)
Increase in refundable deposits and others	299	0
Net cash used in investing activities	(72,483)	(135,899)
Cash flows from financing activities:
Payments of lease liabilities	(4,802)	(5,116)
Proceeds from convertible notes payable -non-current	1,000,000	850,000
Proceeds from notes payable	0	800,000
Repayments of notes payable	(200,000)	0
Net cash provided by financing activities	795,198	1,644,884
Effect from foreign currency exchange	(2,518)	(754)
Net (decrease) increase in cash and cash equivalents	(707,230)	119,850
Cash and cash equivalents at beginning of period	1,853,362	1,751,499
Cash and cash equivalents at end of period	1,146,132	1,871,349
Supplemental disclosures of noncash financing and investing activities:
Issuance of convertible notes for payables - related party	0	26,000,000
Receivable of convertible notes issued	1,500,000	50,000
Net change in equipment payable	$ 0	$ 202,002